跳至主要内容
临床试验/PACTR201712002827168
PACTR201712002827168尚未招募未知

Transfer of healthy gut flora for restoration of intestinal microbiota via enema (THRIVE) for severe acute malnutrition: A pilot study evaluating microbial engraftment, safety and nutritional outcomes

OpenBiome0 个研究点目标入组 20 人开始时间: 2017年11月30日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Month(s) 至 60 Month(s)(—)
性别
All

入选标准

  • 1.Age 18 to 60 months.
  • 2.Stable SAM defined as:
  • a.A WHZ of less than ¿3 according to the 2006 WHO Growth Standards or a mid-upper-arm circumference of less than 115 mm
  • b.No medical complications present
  • c.Participant is sufficiently alert and successfully passes the appetite test which involves consumption of breastmilk or a ready to use therapeutic food (RUTF) under supervision.
  • d.Participant is in the rehabilitation phase of treatment for SAM
  • 3.No bilateral pitting pedal edema or generalized anasarca.
  • 4.HIV negative.
  • 5.Optimal WHO treatment for SAM:
  • oCompleted course of antibiotics as part of standard therapy for SAM within the last 3 months.
  • oDeworming in the last 3 months.
  • oMicronutrient supplementation (Vitamin A, zinc and iron) as recommended by local guidelines
  • oNutritional rehabilitation as recommended by local guidelines
  • 6.Written informed consent obtained by parent or caregiver.

排除标准

  • 1.Evidence of current complicated SAM defined as any of the following:
  • a.Admitted to acute care ward as inpatient
  • b.Signs of acute infection.
  • c.One or more WHO Integrated Management of Childhood Illness danger signs.(2)
  • d.Failure to pass appetite test.
  • e.Presence of known comorbid diseases such as pulmonary Tuberculosis, cystic fibrosis, type I diabetes mellitus, intestinal malabsorptive syndromes, chronic lung disease, chronic liver disease, chronic renal disease or malignancy undergoing active chemotherapy.
  • f.Bilateral pitting pedal edema or generalized anasarca
  • 2.Ongoing antibiotic use for indication other than SAM (e.g. infection, HIV prophylaxis).
  • 3.Congenital malformations, syndromic conditions and metabolic abnormalities (inborn errors of metabolism) that may adversely affect growth.
  • 4.Kwashiorkor or marsmic-kwashiorkor.
  • 5.Bilateral pitting edema Grade 2.
  • 6.Contraindications to enema:
  • a.Anorectal malformations
  • b.Rectal prolapse
  • c.Hirschsprungs disease
  • d.Other contraindication to enema.
  • 7.Primary immune deficiencies
  • 8.Neutropenia
  • 9.Persistent and chronic diarrhea (>7 days of loose or water stools).
  • 10.Dysentery
  • 11.Intestinal abnormalities including malformations, Hirschsprungs disease and short bowel syndrome

研究者

发起方
OpenBiome

相似试验